We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




VisualDx AI App for iPhone Improves Disease Diagnosis

By HospiMedica International staff writers
Posted on 12 Oct 2017
VisualDx (Rochester, NY, USA) has enhanced its VisualDx app with Core ML, a new framework enabling on-device machine learning to help provide healthcare professionals with quick and accurate identification of rashes and skin lesions. More...
The technology will further help non-dermatology practitioners in identifying and treating a variety of skin conditions which were previously difficult to diagnose without a specialist referral.

The full VisualDx suite is a web- and app-based clinical decision support system designed to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient safety. It combines clinical search with a database of more than 41,000 of the best medical images in the world, plus medical knowledge from experts to help with diagnosis, treatment, self-education, and patient communication.

The VisualDx app helps emergency medicine, urgent care and primary care professionals make smarter, faster, more accurate diagnoses and treatment choices based on a series of questions, including global locations, and interfaces with information such as local/regional outbreaks and health and medication history. VisualDx + DermExpert, an addition to the VisualDx subscription, is available for iPhone and iPad on the App Store. The VisualDx technology analyzes photos taken by the clinician and classifies them within a second on an iPhone or iPad. The clinician views and confirms the lesion type classification, enters additional patient information and immediately reviews diagnostic possibilities and treatment options.

“iOS 11 with Core ML enables the type of on-device learning and artificial intelligence that will benefit patients, maintain their privacy, and allow for innovation in companies like ours,” said Art Papier MD, CEO and co-founder of VisualDx. “In a few milliseconds, our app makes a recommendation based on a photo of the condition, augmenting clinical thinking and driving better care.”

Related Links:
VisualDx


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Cardiograph Device
PageWriter TC35
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.